NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE219087 Query DataSets for GSE219087
Status Public on Nov 01, 2023
Title Distant antimetastatic effect of enterotropic colon cancer-derived α4β7 CD8 T cells [scRNA-seq]
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Despite the high prognostic value of immune infiltrates in colorectal cancer (CRC), metastatic disease remains resistant to immunotherapy by immune checkpoint blockade (ICB). Here we show in a metastatic CRC multi-tumor preclinical model that orthotopically-implanted primary colon tumors can spontaneously exert a colon-specific and immune-dependent antimetastatic effect on distant hepatic lesions. An immune signature, integrating antitumor CD8 T cells, dendritic cells and protumor macrophages, that we called MicroEnvironment (ME)-score, was predictive of the antimetastatic effect. ScRNA-Seq and phenotypic analyses revealed that enterotropic α4β7 integrin expressing tumor neoantigen-specific CD8 T cells were key components of the systemic immune response responsible for the antimetastatic effect. Accordingly, the presence of concomitant colon tumors improved the efficacy of proof-of-concept ICB on liver lesions and generated a protective memory immune response whereas antibody-mediated partial depletion of α4β7+ cells abrogated the control of metastatic disease by the primary tumor. Finally, in a metastatic CRC patients’ cohort, we show increased expression of genes encoding the α4β7 integrin and of the ME-score in ICB responsive metastases concomitant with increased proportions of circulating α4β7+ CD8 T cells. Our findings identify a systemic cancer immunosurveillance role for gut primed tumor-specific α4β7+ CD8 T cells. 
 
Overall design Single-cell RNA sequencing was performed on sorted T cells from mice liver and colon tumors and blood samples, harvested at day 10 post tumor implantations (intra-hepatic (IH)+intra-colon (IC) concomitant injections (IH+IC group) or IH alone (al.) injections). Each sample corresponds to a pool of 18 (for IH+IC group) or 9 (for IH al. group) IH tumors; 18 (for IH+IC group) IC tumors; 18 (for IH+IC group) or 9 (for IH al. group) blood samples.
 
Contributor(s) Feliu V, Gomez-Roca C, Michelas M, Thébault N, Lauzeral-Vizcaino F, Salvioni A, Scandella L, Sarot E, Valle C, Balança C, Scarlata C, Delord J, Ayyoub M, Devaud C
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Nov 30, 2022
Last update date Nov 01, 2023
Contact name Christel Devaud
E-mail(s) christel.devaud@inserm.fr
Organization name INSERM
Department UMR1037
Lab CRCT - Team 1
Street address 2 Avenue Hubert Curien
City Toulouse
ZIP/Postal code 31037
Country France
 
Platforms (1)
GPL24247 Illumina NovaSeq 6000 (Mus musculus)
Samples (16)
GSM6767488 intrahepatic injection alone - Control - Liver
GSM6767489 intrahepatic injection alone - Control - Blood
GSM6767490 intracolorectal and intrahepatic injection - Sample 1 - Colon
This SubSeries is part of SuperSeries:
GSE193594 Distant antimetastatic effect of enterotropic colon cancer-derived α4β7 CD8 T cells
Relations
BioProject PRJNA907008

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE219087_RAW.tar 146.5 Mb (http)(custom) TAR (of TAR)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap